Document is current

Any future updates will be listed below

Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation

Crossref DOI link: https://doi.org/10.1007/s10557-014-6558-1

Published Online: 2014-10-16

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark